Barclays Capital Inc. disclosed changes in its holdings of Osmotica Pharmaceuticals plc ordinary shares, including purchases, sales, and derivative transactions. The positive score for this news is 1.2376589438645169e-05. The neutral score for this news is 2.430175243262056e-07. The negative score for this news is 0.9999873638153076.